Polaryx Therapeutics, Inc. (PLYX)
1.61
+0.01
(+0.62%)
USD |
NASDAQ |
Nov 18, 16:00
1.61
0.00 (0.00%)
After-Hours: 20:00
Polaryx Therapeutics Price : 1.61 for Nov. 18, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 18, 2026 | 1.65 | 1.68 | 1.61 | 1.61 | 22335.00 |
| Nov 17, 2026 | 1.62 | 1.671 | 1.56 | 1.60 | 30656.00 |
| Nov 16, 2026 | 1.75 | 1.76 | 1.67 | 1.67 | 14858.00 |
| Nov 13, 2026 | 1.88 | 1.88 | 1.77 | 1.77 | 10406.00 |
| Nov 12, 2026 | 1.91 | 1.945 | 1.85 | 1.88 | 9877.00 |
| Nov 11, 2026 | 1.85 | 1.95 | 1.85 | 1.95 | 7134.00 |
| Nov 10, 2026 | 1.98 | 1.98 | 1.865 | 1.87 | 14832.00 |
| Nov 09, 2026 | 1.82 | 1.95 | 1.80 | 1.94 | 30893.00 |
| Nov 06, 2026 | 1.74 | 1.87 | 1.738 | 1.80 | 23545.00 |
| Nov 05, 2026 | 1.75 | 1.80 | 1.70 | 1.74 | 60160.00 |
| Nov 04, 2026 | 1.79 | 1.85 | 1.760 | 1.80 | 11142.00 |
| Nov 03, 2026 | 1.725 | 1.780 | 1.690 | 1.73 | 25055.00 |
| Nov 02, 2026 | 1.76 | 1.84 | 1.72 | 1.75 | 30241.00 |
| Oct 30, 2026 | 1.860 | 1.89 | 1.75 | 1.75 | 32580.00 |
| Oct 29, 2026 | 1.85 | 1.91 | 1.83 | 1.86 | 15386.00 |
| Oct 28, 2026 | 1.86 | 1.910 | 1.82 | 1.89 | 14704.00 |
| Oct 27, 2026 | 1.83 | 1.91 | 1.822 | 1.88 | 14872.00 |
| Oct 26, 2026 | 1.92 | 1.92 | 1.755 | 1.82 | 27516.00 |
| Oct 23, 2026 | 1.90 | 1.90 | 1.84 | 1.85 | 43032.00 |
| Oct 22, 2026 | 1.85 | 1.990 | 1.85 | 1.94 | 15569.00 |
| Oct 21, 2026 | 1.89 | 1.94 | 1.85 | 1.94 | 13351.00 |
| Oct 20, 2026 | 1.87 | 1.93 | 1.83 | 1.91 | 10086.00 |
| Oct 19, 2026 | 1.89 | 1.92 | 1.84 | 1.92 | 29388.00 |
| Oct 16, 2026 | 1.92 | 2.03 | 1.87 | 1.88 | 19479.00 |
| Oct 15, 2026 | 1.94 | 1.97 | 1.88 | 1.95 | 42606.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cocrystal Pharma, Inc. | 0.9769 |
| CNBX Pharmaceuticals, Inc. | 0.0001 |
| GB Sciences, Inc. | 0.0001 |
| Arvinas, Inc. | 6.765 |
| Fulcrum Therapeutics, Inc. | 3.72 |
Price Related Metrics
| PEG Ratio | -2.087 |
| Price to Book Value | 10.54 |
| Earnings Yield | -11.24% |
| Market Cap | 80.25M |
| PEGY Ratio | -2.087 |